Felice, Carla
 Distribuzione geografica
Continente #
EU - Europa 1.031
NA - Nord America 954
AS - Asia 299
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.291
Nazione #
US - Stati Uniti d'America 944
DE - Germania 511
CN - Cina 135
SE - Svezia 135
SG - Singapore 92
UA - Ucraina 92
IT - Italia 71
GB - Regno Unito 56
FR - Francia 55
IE - Irlanda 35
FI - Finlandia 29
ID - Indonesia 25
IN - India 25
RU - Federazione Russa 15
BE - Belgio 12
CA - Canada 10
TR - Turchia 10
IR - Iran 6
NL - Olanda 5
CI - Costa d'Avorio 3
JP - Giappone 3
PL - Polonia 3
BG - Bulgaria 2
CH - Svizzera 2
ES - Italia 2
GR - Grecia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
MA - Marocco 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
TW - Taiwan 1
Totale 2.291
Città #
Chandler 227
Ashburn 86
Jacksonville 79
Singapore 73
San Mateo 50
Dearborn 47
Ann Arbor 38
New York 38
Nürnberg 37
Dublin 34
Cattolica 30
Nanjing 28
Jakarta 25
Wilmington 24
Munich 21
Milan 19
Bremen 17
Boston 15
Beijing 14
Lawrence 14
Brussels 12
Houston 12
Lancaster 11
Helsinki 10
Izmir 9
Moscow 9
Princeton 9
Leawood 8
Los Angeles 8
Nanchang 8
Detroit 7
Jiaxing 7
Redwood City 7
Seattle 7
London 6
Marseille 6
Mountain View 6
Shenyang 6
Toronto 6
Boardman 5
Changsha 5
Hebei 5
Shanghai 5
Woodbridge 5
Andover 4
Ardabil 4
Fairfield 4
Hefei 4
Redmond 4
Rome 4
Tianjin 4
Abidjan 3
Augusta 3
Costa Mesa 3
Edinburgh 3
Jinan 3
Kunming 3
Simi Valley 3
Washington 3
A Coruña 2
Amsterdam 2
Athens 2
Changchun 2
Frankfurt am Main 2
Fremont 2
Guangzhou 2
Hangzhou 2
Kish 2
Kraków 2
Millbury 2
Napoli 2
Norwalk 2
Paris 2
Pune 2
Raritan 2
Sofia 2
Tappahannock 2
University Park 2
Berlin 1
Bern 1
Bucharest 1
Budapest 1
Casablanca 1
Chengdu 1
Clearwater 1
Delhi 1
Fuzhou 1
Groningen 1
Henderson 1
Ipswich 1
Kyiv 1
Ladispoli 1
Landshut 1
Lanzhou 1
Lisbon 1
Moncalieri 1
Monmouth Junction 1
Montreal 1
Montréal 1
Mumbai 1
Totale 1.207
Nome #
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 154
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 145
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 144
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 140
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 138
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 138
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 136
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 121
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 117
Ileal Crohn's disease: CEUS determination of activity 107
Use of infliximab in particular clinical settings: management based on current evidence. 101
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 91
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 88
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis 84
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 78
Management of perianal fistulas in Crohn's disease: an up-to-date review 77
AID in aging and autoimmune diseases 71
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 71
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases 67
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 65
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis. 50
Biological therapies for inflammatory bowel disease: controversies and future options 48
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 40
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 22
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 16
Totale 2.309
Categoria #
all - tutte 8.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020191 0 0 0 0 0 58 28 16 24 12 31 22
2020/2021178 5 20 3 23 23 4 16 9 24 2 40 9
2021/2022237 27 17 4 39 4 3 3 47 7 4 30 52
2022/2023528 71 73 33 103 33 63 17 40 68 2 15 10
2023/2024244 10 50 6 20 3 50 3 33 10 12 24 23
2024/2025157 5 18 49 11 61 13 0 0 0 0 0 0
Totale 2.309